Tag: Bugworks Research
Bugworks Research to present eight posters at 33rd ECCMID 2023 in...
The eight posters highlight data from the microbiological and efficacy studies of the clinical candidate, BWC0977 that exhibits broad-spectrum activity against a globally, diverse panel of Gram-positive, Gram-negative and biothreat pathogens
“Our lead antibacterial asset is undergoing first-in-human phase-I clinical trials”
Dr Vasan Sambandamurthy, Senior Vice President, Bugworks Research India shares his views on the current biotech and startup scenario, his company’s journey so far, R&D initiatives and future outlook
Bugworks & Cytecare Cancer Hospitals to co-develop cutting-edge immuno-oncology therapies
The outcome of this translational research will guide the first-in-human trials, expected to commence in early 2024
GARDP supports Bugworks in assessing safety of new antibiotic compound
The support of the cardiac safety study follows a memorandum of understanding signed by GARDP and Bugworks in August 2020 to accelerate the development and availability of antibiotic treatments
G S Krishnan takes charge as new president of ABLE
Krishnan heads a nine-member executive council that was elected last January for a three-year term starting on April 1, 2021.................